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Purpose: The North American Subfascial Endoscopic Perforator Surgery (NASEPS) 
Registry was established to evaluate the safety, feasibility, and efficacy of minimally 
invasive ndoscopic Linton operations for treatment of chronic venous insufficiency. 
Methods: Retrospective analysis was performed on the clinical data of 151 patients who 
underwent attempt at 158 SEPS in 17 medical centers in the United States and Canada 
between June 1993 and February 1996. 
Results- SEPS was completed on 155 limbs of 148 patients, 81male and 67 female (mean age, 
56 years; range, 27 to 87 years). Three procedures were aborted. Seven patients had bilateral 
procedures (data from one limb were analyzed). One hundred four limbs (70%) had active 
ulcers, and 22 (15%) had healed ulcers. A single endoscopic port without insufflation was 
used in 66 procedures (45%) and laparoscopic instrumentation, with two or three ports, in 
82 (55%), with CO 2 insttttlation i 78 (53%). A tourniquet was used on 112 patients (76%). 
Concomitant venous procedures were performed in 106 patients (72%; saphenous stripping 
in 71, high ligation in 17, varicosity avulsion in 85). No early deaths or thromboembolism 
occurred. Complications included wound infections (9), superficial thrombophlebitis (5), 
cellulitis (4), and saphenous neuralgia (10). Seven patients with wound infection had open 
ulcers; nine of 10 with neuralgia had concomitant procedures. A roll-on tourniquet caused 
skin necrosis in one patient. The clinical score improved from 9.4 to 2.9 after surgery (p < 
0.0001). Mean follow-up was 5.4 months; 31 patients had -----6 months follow-up. Ulcers 
healed in 88% (75 of 85); recurrence or new ulcer was reported in 3% (4 of 120). 
Conclusions: The SEPS modified Linton operation appears afe, with no postoperative 
deaths or early thromboembolism. Wound infection after SEPS remains important. Early 
results indicate rapid ulcer healing. Prospective valuation of long-term results is war- 
ranted. (J Vasc Surg 1997;25:94-105.) 
An estimated 2.5 million people in the United 
States have chronic venous insufficiency (CVI) of  the 
legs. 1 This advanced venous dysfunction is associated 
with ambulatory venous hypertension and is charac- 
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terized by induration and inflammation f  the skin 
and subcutaneous ti sues, microvascular stasis, accu- 
mulation and activation ofleukocytes in the perimal- 
leolar area, and release of necrotizing lysosomal en- 
zymes, ultimately leading to tissue destruction and 
chronic ulceration. 2,3 These events cause severe pa- 
tient discomfort and lead to considerable disability. 
Loss of  work time and productivity, and costs to the 
patients and the health care system have been esti- 
mated in millions of dollars annually. 4 
Incompetence of perforator veins that connect 
the superficial to the deep venous system has been 
implicated in the pathogenesis ofvenous ulcerations 
94 
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Table I. Risk factors for acute or chronic 
venous'disease in 148 patients 
Risk factors No. of patients (%) 
Previous deep venous thrombosis 45 (30) 
Family history of varicosity 44 (30) 
Smoking 36 (24) 
Limb trauma 31 (21) 
Hypertension* 25 (17) 
Prethrombotic state 23 ( 16 ) 
Malignancy 20 (14) 
Obesity 19 (12) 
Cardiac disease1" 14 (9) 
Diabetes 10 (7) 
Rheumatoid arthritis 8 (5) 
*Diastolic blood pressure >90 mm Hg. 
J'Greater than NYHA class 1. 
since the prescient observations of Gay, Homans, 
and Linton. s-8 In 1938 Linton described an opera- 
tion that included perforating vein interruption. 7 
This drew heavily on the teachings of Homans 6 and 
was designed to correct all. of the observed venous 
pathophysiologic and lymphatic dysfunction. The 
operation was used extensively and was even modi- 
fied as late as 1953. 8 The procedure featured a long 
medial calf incision, which was carried through the 
fascia to expose and interrupt all posterior, medial, 
and paratibial perforators. Modifications in the oper- 
ation were made by several workers, but wound com- 
plications and the need for prolonged hospitalization 
gradually limited use of the procedure. 9-11 Because 
experience reported from several centers suggested 
that venous ulcer recurrence was decreased by perfo- 
rator interruption, alternative methods appeared that 
attempted perforator division without wound mor- 
bidity. These methods used shorter and transverse or 
oblique incisions and blind avulsion of  the perfora- 
tors with specialized shearing instruments. 12-1 sSome 
success was reported, but these procedures did not 
become widely accepted. Beneficial effects of perfora- 
tor vein interruption were emphasized by several 
investigators, 9-15 but some have denied that such 
benefits occurred in limbs that had concomitant deep 
vein incompetence. 16-17 
Exploration of the use of endoscopes in perfora- 
tor vein interruption were begun by Hauer 16 and 
Fischer 17 in the mid-1980s in Europe and were soon 
followed by others. 18-2s Accessing the subfascial 
space and interrupting perforating veins through 
small incisions made in sldn unaffected by the 
changes of severe CVI and remote from ulcerations 
was an attractive concept. Several groups in the 
United States recognized this and used existing 
equipment made available by progress in minimally 
Table II. Signs and symptoms of chronic 
venous insufficiency in 148 patients 
Signs and symptoms Patients (%) 
Pigmentation 136 (92) 
Pain 127 (86) 
Edema 116 (78) 
Ulcer 104 (70) 
Lipodermatosclerosis 103 (70) 
Varicosity 79 (53) 
Venous claudication 21 ( 14 ) 
invasive non-vascular surgical technology. 24-27 Sur- 
geons who were interested in improving the care of 
patients with severe CVI freely communicated and 
embraced the registry concept as a means of accumu- 
lating useful clinical information. Thus the North 
American Subfascial Endoscopic Perforator Surgery 
(NASEPS) Registry was founded, with its first goal 
to evaluate the safety and feasibility of endoscopic 
perforator interruption andsimultaneously to collect 
preliminary information on early outcomes. 
PAT IENTS AND METHODS 
The NASEPS Registry was established to collect 
clinical data on patients who underwent subfascial 
endoscopic perforator vein surgery (SEPS) in 17 in- 
stitutions in the United States and Canada between 
June 15, 1993, and February 15, 1996. The data 
were collected on data sheets for each patient and 
were entered in a computerized database. Patients in 
whom procedures were attempted were also included 
in the Registry. In patients who underwent bilateral 
SEPS procedures, the extremity with the higher pre- 
operative clinical score 28 was used for statistical anal- 
ysis. If  preoperative clinical scores were identical, data 
from the limb with an active ulcer were analyzed. If  no 
ulcer was present or both limbs had ulcers, inclusion 
was determined by a coin flip. To analyze the data, the 
updated clinical classification of CVI was used. 29 Clini- 
cal scoring of venous disease was determined as sug- 
gested by the Consensus Committee of the American 
Venous Forum on Chronic Venous Disease. 28 
The Kaplan-Meier survival analysis was used to 
estimate the probability of ulcer healing. I f  the date 
of the healing was not recorded, the date of the last 
follow-up was used as surrogate date for analysis. To 
determine rapidity of ulcer healing, the cumulative 
distribution function for the time from surgery to 
healing was determined for patients whose date of 
ulcer healing was known. Predictors of ulcer healing 
were assessed using the log-rank test. To determine 
risk factors of wound infection or saphenous neural- 
gia, we used Fisher's exact test to assess categoric 
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Table HI .  Clinical data on 104 limbs with 
active venous ulcers 
Clinical data No. of limbs (%) 
Ulcer size 
-<2 cm 36 (35) 
>2 cm 68 (65) 
Ulcer duration 
<3 months 21 (20) 
>3 months 83 (80) 
Ulcer recurrence 
None 23 (22) 
Once 11 (11) 
More than once 70 (67) 
Number of ulcers 
One 77 (74) 
Multiple 27 (26) 
variables, and the Rank sum test was used for contin- 
uous variables. The sign rank test was used to calcu- 
late surgical outcome scores in those patients who 
had at least 6 months follow-up after SEPS. Statisti- 
cal significance was confirmed ifp was less than 0.05. 
RESULTS 
Data on 151 patients who underwent attempts at 
SEPS on 158 legs were collected. SEPS was aborted 
in three patients because of inability to obtain a 
bloodless field with a tourniquet. Two of these were 
converted to conventional open procedures, and one 
patient had no further surgical treatment. One hun- 
dred forty-eight patients, 81 male and 67 female 
(mean age, 56 years; range, 27 to 87) underwent 
SEPS on 155 limbs. Eighty patients (54%) had SEPS 
on the right leg and 75 (51%) on the left leg. Seven 
patients (5%) underwent bilateral procedures, but 
data from only one limb of the 148 patients with 
completed SEPS were analyzed. At least one risk 
factor for acute or chronic venous disease was present 
in 125 patients (84%) (Table 5). The most frequent 
symptom at presentation was pain (86%) (Table II); 
the most frequent sign was skin pigmentation (92%), 
followed by edema (78%) and ulcer (70%). 
One hundred four extremities (70%) had at least 
one active ulcer (clinical class C6) the time of the 
SEPS procedure (Tables III and IV). Eighty percent 
of the ulcers were present for more than 3 months, 
and 65% were more than 2 cm in size. Seventy ulcers 
(67%) had recurred more than once. 
Preoperative work-up varied at different institu- 
tions. Studies included uplex scan on 110 patients, 
phlebograms in 74 patients, and evaluation by im- 
pedance, strain gauge, air plethysmography, or pho- 
toplethysmography in 50. 
The underlying venous pathophysiologic mecha- 
Table IV. Preoperative classification of 
chronic venous disease in 148 patients 
Category 
No. of 
patients 
(%) 
Clinical class (C) 
Etiology (E) 
Anatomy (A) 
Pathophysiology (P) 
C1: telangiectases or reticular 
veins 
C2: varicose veins 1 (1) 
Ca: edema without skin 2 (1) 
changes 
C4: skin changes ascribed to 19 (13) 
venous disease (e.g. 
pigmentation, venous eczema, 
lipodermatosclerosis) 
Cs: skin changes as defined 22 (15) 
above with healed 
ulceration 
C6: skin changes as defined 104 (70) 
above with active ulceration 
Primary 103 (70) 
Secondary 45 (30) 
Superficial 98 (66) 
Deep 106 (72) 
Perforator 129 (87) 
Reflux 138 (93) 
Obstruction 6 (4) 
Both 3 (2) 
nism was reflux in 138 limbs (93%), obstruction in 
six (4%), (both in three, 2%), and was undetermined 
in 1 (1%) (Table IV). Incompetence of calf perfora- 
tors was found in 128 extremities (86%), no perfora- 
tor reflux could be documented in five extremities 
(3%), and in 15 patients (11%) the perforators were 
either aot  evaluated (eight limbs) or not reported on 
the data sheets (seven limbs) (Table V). Incompe- 
tence of the superficial and perforator system was 
documented in 98 limbs (66%), with 89 (60%) in- 
volving the greater saphenous vein. Isolated incom- 
petence of the superficial system was present in 21 
patients (14%). Incompetence of the deep veins was 
present in 99 limbs (68%). Reflux was isolated to the 
deep system in 29 patients (20%). Combined deep 
and superficial reflux was present in 74 patients 
(51%), of whom 64 (84%) also had perforator reflux. 
Isolated perforator incompetence was noted in eight 
patients (5%). The causes of chronic venous disease 
included primary valvular incompetence in 103 
(70%) and secondary, postthrombotic venous insuf- 
ficiency in 45 patients (30%). 
Before the SEPS procedure all patients had re- 
ceived nonoperative treatment for venous disease. 
Ninety-seven patients (66%) were treated for more 
than 6 months before surgery. Nonoperative man- 
agement included leg elevation in 77 (52%), com- 
pression stockings in 114 (77%), Unna's boot in 77 
(52%), or elastic wrap in 39 patients (26%). Preoper- 
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ative patient compliance as estimated by the care 
providers approached 100% in 72 patients (49%), 
75% in 39 (26%), and 50% or less in 19 (13%). No 
compliance stimate was available for 18 patients. 
Of the 104 patients with active ulcers, 66 (63%) 
were treated without surgery for longer than 6 
months. Seventy-nine of these patients (76%) were 
prescribed elastic stockings. Unna's boot was used in 
63 patients (61%) and elastic wrap in 31 (30%). 
Compliance in this group approached 100% in 52 
patients (50%), 75% in 27 patients (26%), and 50% or 
less in 13 patients (13%), and it was not recorded for 
12 patients (12%). 
Previous urgical treatment included stripping of 
the greater saphenous vein with or without avulsion 
or excision of varicose veins in 25 patients (17%), 
excision or avulsion of varicose veins only in one 
patient (1%), perforator ligation in 12 patients (8%), 
and skin grafting of ulcers on one or several occasions 
in 16 patients (11%). Altogether, 32 of 148 patients 
(22%) had one or several procedures performed on 
superficial or perforator veins before the SEPS proce- 
dure. Three patients had a previous popliteal vein 
valve transplant. 
Surgical techniques of SEPS varied by surgeon 
and institution and included techniques reported 
previously by members of the Registry. 24-27 A single 
endoscopic port of various types (Storz endoscope, 
arthroscope) were used for visualization and dissec- 
tion in 66 patients (45%). 27 Two or three separate 
ports, most using standard laparoscopic nstruments, 
were used in 82 patients (55%; two ports in 79, three 
ports in three patients). Carbon-dioxide gas insuttla- 
tion into the subfascial space was used to improve 
visualization i  78 patients (53%).2s In seven patients 
a 250 ml balloon expander was used to enlarge the 
subfascial plane. A thigh tourniquet was used in 112 
patients (76%) to obtain a bloodless field. Tourni- 
quet time averaged 55.3 minutes (range, 11 to 240 
minutes; not reported in five patients). 
The number of perforating veins interrupted in 
one limb averaged 3.8 (range, 1 to 10; not reported 
in eight patients). SEPS without additional opera- 
tions on superficial veins was performed in 38 pa- 
tients (26%). One hundred six (72%) had concomi- 
tant operations on superficial veins; 88 (49%) had 
operations for saphenous vein incompetence (high 
ligation with stripping, 71; without stripping, 17). 
Sixty-nine of these patients had additional avulsion 
or excision of varicose veins. An additional 16 pa- 
tients had avulsion or excision of varicose veins only 
in addition to the SEPS procedure. Concomitant 
ulcer operations were performed in 18 patients (12%; 
Table V. Distribution and type of venous 
pathology in 145 limbs 
Anatomic site 
Type of venous pathology 
Reflux: Both: no. 
no. of Obstruction/stenosis: oflimbs 
limbs (%) no. of limOs (%) (%) 
Superficial veins 
Greater saphenous vein 89 (61) 4 (3) 4 (3) 
Lesser saphenous vein 16 (11) 2 (1) 2 (1) 
Nonsaphenous 15 (10) 2 (1) 1 (1) 
Total 98 (66) 6 (4) 5 (3) 
Deep veins 
Inferior vena cava - -  3 (2) - -  
Iliac veins 14 (10) 6 (4) 1 (1) 
Femoral veins 84 (60) 14 (9) 5 (3) 
Popliteal vein 75 (52) 15 (10) 7 (5) 
Tibial veins 40 (28) 7 (5) 2 (1) 
Total 99 (68) 28 (19) 9 (6) 
Perforator veins 
Calf perforators 128 (86) 2 (1) 2 (1) 
Thigh perforators 21 (14) 2 (1) i (1) 
Total 129 (89) 3 (2) 2 (I) 
Data not recorded for three patients. 
debridement only, eight patients; split-thickness kin 
graft, 10 patients). 
Perioperative thrombosis prophylaxis included 
elastic ompression i  90 patients (61%), subcutaneous 
heparin in 27 (18%), intravenous heparin in one (i%), 
and low-molecular-weight heparin in eight (5%). Nine 
patients (6%) received warfarin at the time of the SEPS 
procedure. Pneumatic ompression pumps or Plexi- 
pulse was used in 25 patients. Hospital stay averaged 
2.1 days (range, 0 to 31 days), with 66 patients (45%) 
discharged the day of the procedure and an additional 
29 (20%) dismissed after overnight observation. 
There were no early deaths, and there was no 
clinical evidence of thromboembolism within 30 
days of the procedure. Superficial thrombophlebitis 
was reported in five patients, of which three occurred 
within 30 days. One patient with known protein C 
deficiency with a history of multiple episodes of deep 
venous thromboses developed recurrent popliteal 
vein thrombosis 2 months after the operation. Al- 
though this patient had postoperative superficial 
thrombophlebitis, a Duplex scan performed within 1 
week after surgery documented an absence of fresh 
thrombus in the deep system. 
Early complications (within 30 days) also in- 
cluded cellulitis in four patients (3%) and wound 
infections in eight (5%), five at port entry sites and 
three at other incisions. Wound infections after 30 
days developed in two patients, one of whom also 
had early infection. Therefore, the overall incidence 
of wound infection is at least 6% (9 of 148). Seven of 
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Table VI. Association of clinical variables and early surgical complications 
Wound infection Saphenous neuralgia 
Clinical variables (n = 8) p* (n = 6) p* 
Ulcer 
Present 6/79 (7.6%) 3/79 (3.8%) 
Absent 2/29 (6.9%) 1.0 3/29 (10.3%) 0.340 
Saphenous vein stripping 
Done 4/66 (6.1%) 6/66 (9.1%) 
Not done 4/42 (9.5%) 0.709 0/42 (0%) 0.080 
High ligation 
Yes 1/10 (10.0%) 0/10 (0%) 
No 7/98 (7.1%) 0.553 6/98 (6.1%) 1.0 
Tourniquet time 
>60 minutes 1/22 (4.6%) 0/22 (0%) 
<60 minutes 3/59 (5.1%) 1.0 6/59 (10.2%) 0.182 
Endoscopes used 
One 4/55 (7.3%) 4/55 (7.3%) 
Multiple 4/53 (7.6%) 1.0 2/53 (3.9%) 0.679 
C02 insufflation 
Yes 3/52 (5.8%) 2/52 (3.9%) 
No 5/56 (8.9%) 0.718 4/56 (7.1%) 0.680 
Varicose vein'avulsion 
Yes 4/53 (7.6%) 6/53 (11.3%) 
No 4/55 (7.3%) 1.0 0/55 (0%) 0.012 
Diabetes 
Yes 0/4 (0%) 0/4 (0%) 
No 8/100 (8.0%) 1.0 6/100 (6.0%) 1.0 
Gender 
Female 5/49 (10.2%) 5/49 (10.2%) 
Male 3/59 (5.1%) 0.464 1/59 (1.7%) 0.09 
*Fisher's exact est. 
the nine patients with wound infections had active 
ulcers at the time of the SEPS procedure. We failed 
to identify, however, any clinical factors that pre- 
dicted the development ofwound infection in these 
patients (Table VI). 
Nine of the 10 patients with saphenous neuralgia 
underwent stripping of the greater saphenous vein 
(eight from groin to knee, one from groin to ankle). 
Only avulsion of varicose veins was found as a clinical 
variable significantly associated with saphenous neu- 
ralgia (Table VI). A roll-on tourniquet 27caused skin 
necrosis in one patient. 
After surgery, elastic stockings were prescribed 
for 94 patients (64%), Unna's boots for 15 (10%), 
elastic wrap for eight (5%), and leg elevation was 
recommended to 51 patients (34%). Fourteen pa- 
tients had no supportive treatment, and in 23 pa- 
tients this was not reported. Postoperative compli- 
ance approached 100% in 76 patients (51%), 75% in 
25 patients (17%), 50% or less in 12 patients (8%), 
and was not reported in 35 patients (24%). 
Follow-up data (with at least one follow-up visit) 
was available for 120 patients (81%) in this series. 
The mean follow-up was 5.4 months (range, 0.4 to 
26.4 months). There was significant improvement i  
the grade of symptoms and signs as measured by the 
clinical score after surgery? 8 The average preopera- 
tive clinical score was 9.4 (range, 0 to 18) and de- 
creased to 2.9 (range, 0 to 12) (p < 0.0001) (Table 
VII). To evaluate clinical outcome, we also used 
another scoring system of the updated classifica- 
tion. 29 Moderate improvement with a score of 
+2.23 (range, 0 to 3) was calculated for a group of 
31 patients who had clinical follow-up beyond 6 
months after surgery (p < 0.0001). 
Follow-up data was available for at least one fol- 
low-up visit for 85 patients who had active ulcers at 
the time of surgery. Seventy-five ulcers (88%) had 
healed on follow-up. The probability of ulcer healing 
at 30 days after surgery was 15% (95% confidence 
interval [CI] 7% to 23%), at 90 days it was 67% (95% 
CI, 55% to 76%) and at 180 days it was 79% (95% CI, 
68% to 87%) (SE, <10%; Fig. 1). Cumulative distri- 
bution function (Fig. 2) of ulcer healing revealed 
that in 31 patients whose date of ulcer healing was 
known the mean healing time after surgery was 42 
days (median, 38 days; range, 14 to 144 days). Fol- 
low-up averaged 5.4 months for those patients 
whose ulcers healed and 7.1 months for the 10 pa- 
tients with persistent ulcers. Four patients, three with 
active ulcers at the time of the operation, developed 
recurrent ulcers during follow-up. Of the 10 ulcers 
JOURNAL OF VASCULAR SURGERY 
Volume 25, Number 1 Gloviczki et al. 99 
Table VII. Mean clinical scores before and after surgical treatment in 114 limbs 
Category Scoring system Mean preoperative score Mean postoperative score 
Pain 0 = none 
1 = moderate,  not  requir ing analgesics 1.14 0.22 
2 = severe, requir ing analgesics 
Edema 0 = none 
1 = mi ld /moderate  0.94 0.43 
2 = severe 
Venous claudication 0 = none 
1 = mi ld /moderate  0:15 0.04 
2 = severe 
P igmentat ion 0 = none 
1 = localized 1.29 . 0.99 
2 = extensive 
Lipodermatosclerosis 0 = none 
1 = localized 1.02 0.69 
2 = extensive 
Ulcer size: (largest ulcer) 0 = none 
1 <2 cm diameter 1.26 0.18 
2 >2 cm diameter 
Ulcer: durat ion 0 = none 
1 = <3 months  1.39 0.20 
2 = ->3 months  
Ulcer: recurrence 0 = none 
1 = once 1.24 0.04 
2 = more  than once 
Ulcer: number  0 = none 
I = single 1.00 0 . I5  
2 = multiple 
Total  mean clinical score* 9.43 2.94 
Patients with both preoperative and postoperative clinical scores reported. 
*p < 0.005. 
that did not heal during follow-up, nine were greater 
than 2 cm in size and nine were present for more 
than 3 months before SEPS. Preoperative ulcer size 
less than 2 cm predicted a significant chance of heal- 
ing the ulcer with SEPS (p < 0.0039) (Table VIII). 
Ancillary venous procedures or the type of the endo- 
scopic procedures had no effect on ulcer healing. The 
presence of deep venous incompetence did not ad- 
versely affect clinical outcome. The preoperative clin- 
ical score in 99 patients with deep venous reflux was 
9.0, and it improved to 3.2 after surgery (p < 0.001). 
Forty-six of the 56 patients with active ulcers (86%) 
who had deep venous reflux had healing of their 
ulcer during follow-up. Three of these patients (7%), 
however, developed recurrent ulcers. 
Thirty-eight patients (26%) underwent SEPS 
without additional operations on superficial veins. 
Thirty-two of these patients had active ulcer. Twen- 
ty-seven of the 32 patients had atleast one follow-up 
visit. Ulcer healing was reported in 21 patients 
(78%). However, three of the 21 patients had early 
recurrence. All three had deep venous incompetence, 
and two had concomitant superficial incompetence. 
In contrast, ulcer healed in 93% (52 of 56) of the 
patients who had concomitant operations on super- 
ficial veins. 
DISCUSSION 
Analysis of data submitted to he NASEPS Reg- 
istry confirms that SEPS modified Linton operations 
are safe. There have been no deaths or clinically 
evident serious early thromboembolism in this series 
of 148 patients, who underwent surgery in 17 cen- 
ters in the United States and Canada. Among early 
complications, wound infection in patients with ac- 
tive ulcers remains a problem, but not as serious a 
complication as was experienced with the open Lin- 
ton procedure, zl Because of the short follow-up of 
most of the patients, no attempt was made in this 
study to investigate the long-term benefit of surgical 
treatment for advanced CVI. 
This compilation of cases reported to the 
NASEPS Registry also revealed that limbs of patients 
selected for surgical intervention were severely af- 
flicted. Active ulcers (class 6) were present in 70% of 
the operated limbs and healed ulcers (class 5) in an 
additional 15%. Seventy percent of limbs selected for 
subfascial intervention had primary rather than post- 
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Fig. 1. Probability of ulcer healing in 85 patients. Bars 
indicate 95% confidence intervals. B ack squares indicate 
last follow-up date ofnonhealed ulcers. 
thrombotic valvular incompetence. This fact is im- 
portant not only because it confirms the dominance 
of primary venous dysfunction i the cause of chronic 
venous disease, as found in previous reports, 3° but 
also because it implie s that many of the so called 
"postphlebitic" patients are suitable candidates for 
surgical intervention. That intervention may be sim- 
ple superficial venous stripping, ablation of clusters 
of varicose veins, or subfascial perforator vein inter- 
ruption, alone or in combination, rather than more 
complex and demanding deep venous reconstruc- 
tions. 
Venous ulcerations have been associated with 
deep and perforator venous reflux in most series, and 
only few reports implicated previously the impor- 
tance of the superficial venous ystem. Venous hemo- 
dynamic studies using color-flow duplex images in 
112 limbs by the St. Mary's group in London found 
superficial incompetence in 84% of the patients with 
venous ulcers, and superficial incompetence alone 
was seen in 23%. 31 Isolated perforator incompetence 
was present in only 3%. Because variable patterns of 
val~atlar incompetence were found in over two thirds 
of the patients, these authors concur with our sug- 
gestions that thorough preoperative duplex evalua- 
tion of the patients is needed to target appropriate 
areas in the venous ystem. A similar variability in the 
distribution of reflux was found in our series as well, 
with 66% of all patients having superficial reflux, 43% 
having combined superficial and deep venous reflux, 
and only 5% having isolated perforator incompe- 
tence. These findings confirm that many patients 
with severe chronic venous insufficiency have a major 
component of superficial rather than isolated deep 
venous insufficiency. 
It is noteworthy that only 86% of our patients had 
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Fig. 2. Cumulative distribution function of ulcer healing 
in 31 patients. 
documented perforator incompetence. This may re- 
flect the incompleteness of our data collection, the 
presumed inability of currently available techniques 
(duplex scanning, venogram) in some centers to 
identify all cases of perforator incompetence, or the 
decision to attempt surgical treatment in patients 
with persistent ulcers with a diagnosis based xclu- 
sively on clinical grounds. 
These preliminary results indicate acceleration of 
ulcer healing even in recalcitrant ulcers. Previously, 
Mayberry et al. 3z indicated that nonoperative man- 
agement of venous tasis ulcerations, including initial 
bed rest, ulcer cleansing, dressing changes, and am- 
bulatory elastic stocking compression therapy, re- 
sulted in initial ulcer healing in 93% of 119 patients 
in a mean of 5.3 months (range, up to 40). Similarly, 
nonsurgical therapy with its attendant costs had been 
applied for more than 6 months in two thirds of the 
patients reported to the Registry. The most expen- 
sive of nonsurgical therapies, the Unna's boot, had 
been used on 52% of all limbs and on 61% of limbs 
with active ulceration. Data submitted to the 
NASEPS Registry showed initial ulcer healing in 88% 
of 85 patients, although follow-up averaged only 7.1 
months in patients with nonhealed ulcers. More im- 
portantly, 67% of the ulcers were healed after SEPS 
by 3 months. In a subset of 31 patients in whom the 
date of ulcer healing was reported, the median post- 
operative time to ulcer healing was 38 days (range, 
0.5 to 4.8 days). This strongly suggests that SEPS 
has a favorable ffect on ulcer healing. 
A sizable number of limbs had failed previous 
surgical intervention, ot directed at the perforating 
veins (i8%). Eleven percent underwent failed skin 
grafting procedures. Altogether, surgical interven- 
tion not including subfascial exploration had been 
done previously in 32 of i48 limbs (22%). 
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Table V I I I .  Clinical factors predicting healing of  venous ulcers at 6 months after surgery 
Clinical factors No. of limbs % healed 95% CI Log rank p value 
Ulcer duration 
<3 months 15 7.71 39.2 to 91.4 
>3 months 63 79.6 66.0 to 87.7 0.7141 
Ulcer size 
<2 cm 26 93.3 70.9 to 98.0 
>2 cm 52 71.5 55.1 to 82.0 0.0039 
Ulcer recurrence 
None 17 76.6 41.1 to 90.7 
One 9 66.7 16.0 to 86.8 
Multiple 55 81.0 66.2 to 89.3 0.5396 
Ulcer recurrence 
--<1 26 73.0 47.8 to 86.0 
Multiple 55 81.0 66.2 to 89.3 0.6690 
Ulcers 
Single 54 71.8% 67.1 to 89.9 
Multiple 24 72.7 46.0 to 86.2 0.2010 
Ancillary venous procedures 
No 28 71.0 45.5 to 84.6 
Yes 57 83.2 69.8 to 91.2 0.1677 
Deep venous incompetence 
No 25 80.4 54.5 to 91~5 
Yes 56 77.7 62.9 to 86.6 0.3039 
Endoscopic ports 
Single 38 76.3 57.3 to 86.8 
Multiple 47 81.9 65.4 to 90.5 0.4396 
CO2 insutflation 
No 39 74.2% 55.4 to 85.1 
Yes 46 83.9 67.3 to 92.1 0.2563 
Major, clinically significant deep vein thrombosis 
did not occur within 30 days of the operation. Recur- 
rent popliteal vein thrombosis was, however, re- 
ported in one patient with protein C deficiency 2 
months after SEPS. Because all direct medial perfo- 
rator veins join the paired posterior tibial veins, 33 the 
potential for deep venous injury and tibial vein throm- 
boris exists. Leg elevation, early ambulation, and elastic 
compression should be used in all patients. Although 
subcutaneous heparin or low-molecular-weight hepa- 
fin has been used in only 23% of our patients, prophy- 
laxis should be considered in all postthrombotic pa- 
tients and in patients with known coagulation 
abnormalities. While the roll-on tourniquet resulted in 
skin necrosis in one patient, no complication was re- 
ported with pneumatic tourniquets, where constant 
pressure (200 to 300 mmHg)  can be maintained and 
continuously monitored ttring the procedure. 
In addition to decreased perioperative complica- 
tions, the advantage of SEPS over the open Linton 
operation may lie in a shorter period of hospitaliza- 
tion. Sixty-five percent of the patients who under- 
went surgery for perforator incompetence using 
SEPS were discharged either on the day of surgery or 
within 24 hours of overnight observation. 
This is the first large series of venous interven- 
tions that has used an objective clinical score as a 
means of measuring early results. The clinical score is 
the sum of assessment of such factors as edema, pain, 
pigmentation, ulcer activity, and size, as well as other 
abnormalities such as venous claudication. 2sBefore 
surgery, the clinical score ranged up to 18 (average, 
9.4) in all limbs reported. After surgery, the clinical 
score was as high as 12, but averaged 2.9 (p < 0.005) 
in limbs in which it was possible to register a score at 
follow-up visit. 
The classic Linton operation was combined with 
skin grafting in many instances. This fact and the 
problems of infection and poor healing of  the surgi- 
cal incision obscured observations regarding ulcer 
healing. The endoscopic approach to perforators in 
cases in this Registry made the effect on ulcer healing 
more clear. The ulcers being treated were severe. 
Sixty-five percent were greater than 2 cm in size, 80% 
had been present for more than 3 months, and two 
thirds had recurred more than once. Eventually, 88% 
of the ulcers healed, and in a subset of  patients it did 
so in a median interval of  38 days. This was achieved 
at a price. Infection developed in seven of 104 limbs 
with an active ulcer at time of  intervention (6.7%), 
and skin grafting was judged to be necessary in 10 
patients. 
Concomitant operations deemed necessary at the 
time of  perforator interruption clouded effects of the 
perforating vein intervention alone as opposed to the 
solitary ablation of superficial reflux. However, there 
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were 38 limbs reported in which the only manipula- 
tion was perforator interruption. Twenty-seven of 
these patients with active ulcers had reached at least 
one follow-up visit, and ulcer healing had been 
achieved in 21 (78%). Recurrent ulcerations ap- 
peared in three limbs with deep venous system in- 
competence. Whether these limbs were suitable for 
deep system repair is unknown. Ulcers recurred in 
two limbs with superficial system reflux, and these 
teach the importance of correcting as much of the 
venous system dysfunction as possible at the time of 
primary intervention. 
Although the operation appears to be safe and 
adaptable to outpatient usage and appears to aid or 
even hasten venous ulcer healing, its long-term re- 
suits have yet to be determined. Continued observa- 
tion and prospective evaluation of limbs entered into 
the Registry during more recent experience seems 
warranted. Preoperative evaluation with duplex scan- 
ning is not yet perfected in every institution, there is 
a learning curve to the operation, and instrumenta- 
tion needs to be improved. So the results achieved to 
date and reported here must be considered to be not 
only preliminary but capable of  substantial improve- 
ment. There is much to be learned about severe 
chronic venous insufficiency and its treatment. It 
appears that the Registry mechanism provides a way 
in which such information can be gathered and many 
facts learned at minimal cost in time, effort, and ex- 
pense. Although not a substitute for prospective, ran- 
domized studies, the NASEPS Registry can provide 
relatively quick, useful data. Furore studies may answer 
some questions, such as in which limbs with advanced 
chronic venous insufficiency is the addition of SEPS 
mandatory, or in which it will be sufficient to correct 
only the superficial venous system incompetence. 
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APPENDIX  I. PART IC IPAT ING CENTERS 
AND SURGEONS OF THE NASEPS 
REGISTRY 
Emory Clinic, Atlanta: Alan Lumsden,  MD.  Jobst 
Vascular Center, Toledo, Ohio: John P. Pigott, MD,  
Hugh G. Beebe, MD,  Steven M. Dosick, MD,  
Steven S. Gale, MD,  Michael G. Vitti, MD,  Ralph C. 
Whalen, MD.  Loma Linda (Calif.) Surgery Medical 
Group: John J. Bergan, MD,  Jeffrey L. Ballard, MD.  
Maimonides Medical Center, Brooklyn, N.Y.: Enrico 
Ascer, MD.  Mayo Clinic, Rochester, Minn.: Peter 
Gloviczki, MD,  Sunil S. Menawat, MD.  Medical 
College of  Wisconsin, Milwaukee: Robert  A. Cam- 
bria, MD.  Mount  Sinai Medical Center, New York: 
Harry Schanzer, MD,  Milan Sldadany, MD.  Naval 
Medical Center, San Diego: Jay Murray, MD.  New 
England Medical Center, Boston: Thomas F. 
O'Donnel l ,  MD,  Mark Iafrati, MD.  Pennsylvania 
Hospital,  Philadelphia: Keith D. Calligaro, MD,  
Matthew J. Dougherty,  MD.  Scripps Memorial  Hos-  
pital, La Jolla, Calif.: John J. Bergan, MD.  Straub 
Clinic & Hospital,  Honolulu:  Robert  L. Kistner, 
MD,  Bo G. Eldof, MD,  Elna Masuda, MD.  Toronto  
General Hospital: Peter Kalman, MD,  Barry Rubin, 
MD.  University of  Nevada, Reno: Ralph G. De- 
Palma, MD.  University of  Pittsburgh: Robert  Y. 
Rhee, MD.  University of  Utah, Salt Lake City: Peter 
F. Lawrence, MD,  Spencer W. Gait, MD,  Douglas L. 
Jicka, MD.  Washington University School o f  Medi- 
cine, St. Louis: Brian G. Rubin, MD.  
DISCUSSION 
Dr. Gregory L. Moneta (Portland, Ore.). This manu- 
script has 41 paragraphs and 22 authors, which is less than 
two paragraphs per author. This is a level of participation 
that is normally reserved only for department chairmen. 
Your authors have bright futures. 
The paper concerns the safety, feasibility, and efficacy 
of subfascial endoscopic perforator surgery, or SEPS. The 
conclusions regarding safety, I believe, are valid. Those 
that address feasibility require clarification. And claims of 
efficacy are not yet justified. 
SEPS appears afe. There were no perioperative deaths 
or recognized thromboembolism. Wound infection oc- 
curred in 6% of patients, which is undesirable but not 
surprising iven the patient population. Because one of the 
goals of SEPS is to minimize wound problems associated 
with perforator ligation, do the authors have any additional 
ideas on how to decrease this complication? 
SEPS may be feasible. The procedure was aborted in 
only three instances. This low incidence of aborted proce- 
dures indicates that ports could be placed and the opera- 
tion attempted. It does not indicate that intraoperative 
goals were accomplished. The primary intraoperative goal 
is presumably ablation of perforator veins beneath areas of 
lipodermatosclerosis and ulceration. How often was it pos- 
sible to pass the endoscope to the ankle and beneath the 
venous ulcer? How successful were the authors in actually 
ligating large and not just trivial perforators, particularly 
beneath severely lipodermatosclerotic skin or venous ul- 
cers? 
With respect o efficacy, the authors purport to have 
built a better mousetrap. We must ask, however, if the 
mouse really needs catching. 
Perforator ligation for venous ulcer is widely known, 
but it is performed infrequently by many savvy practicing 
surgeons. Why is that? The authors uggest that the reason 
is the dissatisfaction with wound complications. I submit 
that a lack of proven superior efficacy over nonoperative 
therapy also has something to do with it. We have reported 
97% ulcer healing in compliant patients who were treated 
only with stockings. The total recurrence in compliant 
patients was 16%. I reviewed nine other reports of subfas- 
cial perforator ligation. The total recurrence varied from 
6% to 55%. One of Dr. Linton's former trainees who 
practices in Portland told me that Dr. Linton said, looking 
back on this operation, that a Linton procedure plus a 
good stocking was as good as the stocking alone. Dr. 
Linton is acknowledged as a wise man. 
The efficacy of SEPS cannot be evaluated from the data 
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that were presented. Although many of the patients who 
underwent SEPS were also treated with compression, we 
do not know how well they were treated before the opera- 
tion or whether they were already well on the way to 
healing before they underwent SEPS. Seventy-two percent 
of the patients in the SEPS registry underwent other ve- 
nous procedures that were performed along with SEPS, 
and at least 80% were treated with compression after sur- 
gery. An alternative view is that at least SEPS did not 
appear to hurt too much. 
The efficacy of this procedure will only be established 
through a randomized trial. It is not the responsibility of
skeptics ,to disprove its value; rather it is the responsibility 
of proponents of the procedure to prove its value. I hope 
that the enthusiasts for SEPS, and in particular the equip- 
ment manufacturers, will have the resolve and responsibil- 
ity to conduct a proper trial. It will be too bad if they do 
not. Finding a proven method to decrease venous ulcer 
recurrence and improve healing in these patients would be 
a real advance in the care of this difficult problem. 
Dr. Peter Gloviczki. I would like to thank Dr. Mo- 
neta for his thoughtful comments and critique. As he just 
said, having a proven method to decrease the recurrence of
venous ulcers would be a real advantage in dealing with 
this difficult problem, which also means that even in Port- 
land, where the conservative management of venous ulcers 
has an excellent record of success, recurrence of venous 
ulcers remains an unresolved problem. We believe that 
endoscopic perforator ligation may be the procedure that 
Dr. Moneta is looking for. 
We agree with his comments that wound complica- 
tions are still significant. Unfortunately, the statistical anal- 
ysis we performed failed to identify any predictor of infec- 
tion, including unhealed ulcers, so we encourage other 
surgeons to continue to offer this operation even to pa- 
tients who have active ulcers. We would treat, however, 
active infection of the ulcer before the operation. 
Yes, it is possible to pass the scope under the ulcer if it 
is located above the ankle. It was an interesting observation 
during these operations that the fascia was practically al- 
ways intact under an ulcer. 
As far as the size and the location of the perforating 
veins are concerned, I have to agree that the retromalleolar 
perforator is difficult o reach and, in fact, occlusion of the 
Cockett I perforator was reported in only 33 operations. 
This was in contrast to the ability to occlude Cockett II 
veins, which are perforators located 7to 9 cm above the ankle, 
which were occluded in 82 patients. The more proximal 
Cockett III perforators were occluded in 76 patients. 
It is not a problem to control large veins. The average 
number of perforators occluded in this series was 3.8. The 
average number of perforators above 2 mm in size was 2.8. 
This number, however, may not be accurate because we 
used exsanguination a d tourniquet in most of the cases. 
We have only short-term data to evaluate at this point 
the efficacy of the procedure. We were definitely impressed 
by the rapidity of the ulcer healing in our patients. These 
patients had conservative management before and after the 
operation, and compliance with compression treatment 
was practically identical before and after the operation. 
I would like to mention that in a subset of patients for 
whom we knew exactly the date of healing, the mean 
number of days from surgery to healing was 42 days. In the 
Portland series, the median time to healing was 5.3 months 
after the treatment was started. 
I have to agree that 72% of the patients underwent an 
associated operation to reat superficial vein incompetence. 
We had, however, a group of patients who underwent an 
isolated SEPS procedure and did not undergo any other 
intervention. In this group we had 27 patients who had 
active ulcers who returned for follow-up; 78% of the ulcers 
were healed after the SEPS operation. 
Finally, we all agree that Dr. Linton was a wise man. 
He designed a good operation which, unfortunately, fell 
into disuse because of wound complications and the need 
for prolonged hospitalization. We all believe that Dr. Lin- 
ton, who was the ninth president of our Society, would be 
very pleased to hear these early results of this registry, and 
he would encourage us to assess late outcome to define the 
ultimate role of his operation in the treatment of venous 
ulcers. 
Dr. Stanley L. Minken (Baltimore, Md.). I agree that 
the use of the subfascial approach appears to be what is 
down the road. We are still using the open approach and 
have found a similar number--that least 75% of our 
patients have required other procedures than just subfascial 
perforator ligation. We have performed all of these proce- 
dures, however, in outpatients. We have not had any ad- 
mission for these patients, and I noticed that the length of 
your admissions averaged 2.1 days. If there were wound 
infections in the groin for the high ligations, we have 
managed them as outpatients. I was wondering why you 
had so many admissions. 
Dr. Gloviczki. In our practice at the Mayo Clinic, we 
now discharge very patient after overnight observation. 
So I think that this is an outpatient procedure. I presume 
that ulcer care probably was one reason and, in some of the 
patients, infection was the other reason why these patients 
in our multicenter study were kept in the hospital longer. 
Dr. Kevin G. Burnand (London, United Kingdom.). 
I agree with everything that Dr. Moneta said about control 
trials, that you have not shown any proven efficacy. I 
suspect that you have been rather selective in your group of 
patients, because if you add up your figures, 70% of your 
ulcers were less than 2 cm 2 in size, and one would predict 
that those are going to heal fairly rapidly. What you haven't 
told us is what additional measures you gave to these 
patients after they had left the hospital, because obviously 
that may have some considerable bearing on healing, 
which may have been different to the preoperative manage- 
ment. Finally, have you made any measurement of calf 
pump function before and after your perforator vein liga- 
tion to prove to us that you have actually achieved some- 
thing on these patients in a physiologic way? 
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Dr. Gloviczki. Thank you for your questions. As far as 
the sizes of the ulcers are concerned, we found that 65% of 
the ulcers in our study were greater than 2 cm. We also 
looked very carefully at the preoperative and postoperative 
conservative treatment. I have to tell you that compression 
stockings or elastic wraps were prescribed for all of our 
patients. Patient compliance was estimated by the investi- 
gators to be equal before and after surgery. However, 50% 
of the patients had an Unna's boot before surgery, but only 
10% were treated with Unna's boots after surgery. 
As far as evaluation of the pump function is concerned, 
we do not yet have good long-term follow-up, and do not 
have evidence of fimctional improvement. So this is one part 
of the data that we are going to concentrate on in the future. 
Dr. David C. Keyes (Bay City, Mich.). I don't have a 
question for Dr. Gloviczki. I think he presented a very nice 
original paper. I rise only to contribute to the Society 
because I have performed four cases; however, I do it a 
little bit differently than you described. All of these four 
cases were C6 ulcers. I used a Storz mediastinoscope. I 
didn't use insutflation. The reason why I did that is because 
the mediastinoscope gives more room for aspiration. It is 
wider than the instrument you use. Also, at the same time I
use papaverine to vasodilate the Cockett veins. And at the 
end of the procedure, I am finished with an incision no 
more than an inch in length. I apply Cutinova Hydro on 
the top of the ulcer. These four patients came in the 
morning and went home in the afternoon. I also use 
Cefazolin, 1 gram intravenously, one hour before surgery 
and another dose after surgery. 
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